TINOS THERAPEUTICS

Owner

Goods & Services

Custom manufacturing of pharmaceuticals

Pharmaceutical products development; Pharmaceutical research and development

Genetic analysis for medical purposes

pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); pharmaceuticals, namely, viral vector therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)